Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SUBLOCADE DIN 02483092

Status: Marketed
Holder: INDIVIOR UK LIMITED
Molecule: BUPRENORPHINE

Health Canada record

Active ingredient(s)BUPRENORPHINE 300 MG
Dosage formSolution (Extended-Release)
RouteSubcutaneous
ScheduleNARCOTICS (CDSA I)
ClassHuman
ATCN07BC01 BUPRENORPHINE
Original market date03-Feb-2020
Current status date03-Feb-2020
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BUPRENORPHINE

DINProductCompanyFormStrengthStatus
02341212BUTRANS 10PURDUE PHARMAPatchBUPRENORPHINE 10 MCGMarketed
02450771BUTRANS 15PURDUE PHARMAPatchBUPRENORPHINE 15 MCGMarketed
02341220BUTRANS 20PURDUE PHARMAPatchBUPRENORPHINE 20 MCGMarketed
02341174BUTRANS 5PURDUE PHARMAPatchBUPRENORPHINE 5 MCGMarketed
02483084SUBLOCADEINDIVIOR UK LIMITEDSolution (Extended-Release)BUPRENORPHINE 100 MGMarketed
02493608BAR-BUPRENORPHINEBARD PHARMACEUTICALS (1990) INCPatchBUPRENORPHINE 5 MCGCancelled Pre Market
02493616BAR-BUPRENORPHINEBARD PHARMACEUTICALS (1990) INCPatchBUPRENORPHINE 10 MCGCancelled Pre Market
02493624BAR-BUPRENORPHINEBARD PHARMACEUTICALS (1990) INCPatchBUPRENORPHINE 15 MCGCancelled Pre Market
02493632BAR-BUPRENORPHINEBARD PHARMACEUTICALS (1990) INCPatchBUPRENORPHINE 20 MCGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
215452018-11-21New Drug Submission (NDS)

International API supply for BUPRENORPHINE

11 valid EDQM Certificates of Suitability from 10 holders. 28 active FDA Drug Master Files.

Request a quote for SUBLOCADE

How to read a Canadian DIN record